Concourse Financial Group Securities, Inc. Intra Cellular Therapies, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$67.99 - $80.84 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$64.76 - $79.84 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$64.37 - $75.65 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$46.37 - $73.65 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$52.09 - $64.1 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$52.09 - $64.1 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$54.67 - $66.44 $0 - $0
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$44.07 - $54.45 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$42.7 - $59.99 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$43.0 - $65.64 $0 - $0
Q1 2022 May 09, 2022	BUY	$38.74 - $62.09 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$35.2 - $53.42 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$28.72 - $42.49 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$29.3 - $44.5 $0 - $0
Q1 2021 May 13, 2021	BUY	$30.8 - $39.51 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$23.34 - $32.22 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$14.35 - $26.64 $0 - $0
Q1 2020 May 13, 2020	BUY	$12.31 - $33.12 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$7.47 - $14.03 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$10.65 - $14.29 $0 - $0
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$17.77 - $22.9 $0 - $0

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$825 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$542 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$453 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$330 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$261 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.09B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account